Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Joey Frenette

Is Pfizer Stock a Buy Near 52-Week Lows for Its 5.08% Yield?

Pfizer (PFE) stock has fallen quite a long way since peaking back in December 2021 at over $59 per share. The COVID-19 vaccine boom helped propel shares to highs not seen in decades. 

Fast forward to today, and the stock is fresh off a vicious 46% implosion from those highs. It's hard to believe, but shares are right back to where they were back in 2020, well before Pfizer unveiled its mRNA vaccine to combat the COVID-19 pandemic. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.